• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ICU MEDICAL DE MEXICO, S. DE R.L. DE C.V. SPINNING SPIROS® CLOSED MALE LUER, PURPLE CAP; SET, ADMINISTRATION, INTRAVASCULAR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ICU MEDICAL DE MEXICO, S. DE R.L. DE C.V. SPINNING SPIROS® CLOSED MALE LUER, PURPLE CAP; SET, ADMINISTRATION, INTRAVASCULAR Back to Search Results
Catalog Number CH2000S-PC
Device Problems Disconnection (1171); Fluid/Blood Leak (1250)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 10/28/2023
Event Type  malfunction  
Manufacturer Narrative
The device is available to be returned for evaluation; however, it has not yet been received.Section e additional contact details: (b)(4).
 
Event Description
The complaint/event involved a spinning spiros® closed male luer, purple cap.A five year old child patient was getting a high-dose of chemotherapy (busulfan-melphalan) for high-risk neuroblastoma.Two hours after connecting the busulfan syringe (during infusion), the professionals were alerted by the patient's family due an early end of infusion alarm.Observation of chemotherapy on the ground and the disconnection of the spiros connector from the syringe.The valve was connected during preparation in the centralized unit and the connection checked during installation of the infusion.Clinical consequences: significant venous return and occlusion of the needle of the implantable catheter port.Removal of the a pulmonary artery catheter (pac) needle and installation of a new needle.A loss of opportunity was reported due to non-complete administration of chemotherapy.Application of the contact protocol with chemotherapy for professionals and the environment.The customer stated there were no noted undesirable clinical consequences and nobody has been hurt.There was no delay in therapy.There was no blood loss considered clinically significant.The leak did not come into contact with the patient and there was no unprotected exposure to chemotherapy for the patient.A specific kit was used to clean the leak.The patient did not receive the full intended dose.About the patient's condition before, during and after the incident, it was reported that there was nothing to signal.No other information was provided.
 
Manufacturer Narrative
One used spinning spiros closed male luer, purple cap, one used 50ml syringe, and one used 4-way stopcock w/ tubing were provided by the customer for evaluation.The spiros came disconnected from the 50ml syringe.As received, no damage was noted on the spiros or the 4 way stopcock.Damage on the threads of the 50 ml syringe male luer was also identified.The spin feature of the spiros was functionally tested and met product performance specifications.The luers of the returned syringe was also analyzed and met iso standards for luer fittings.The reported complaint of a disconnection and subsequent leakage can be confirmed based on the spiros being disconnected from the syringe upon arrival.The probable cause of this separation is due to the damage found on the syringe threads typical of a bending force.A device history record review was performed and no relevant nonconformances were found.D9: date returned to mfg: 14dec2023.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SPINNING SPIROS® CLOSED MALE LUER, PURPLE CAP
Type of Device
SET, ADMINISTRATION, INTRAVASCULAR
Manufacturer (Section D)
ICU MEDICAL DE MEXICO, S. DE R.L. DE C.V.
avenida cuarzo no. 250
ensenada, b.cfa. 22790
MX  22790
Manufacturer Contact
reed covert
600 n. field dr.
lake forest, IL 60045
2247062300
MDR Report Key18287673
MDR Text Key330668466
Report Number9617594-2023-01100
Device Sequence Number1
Product Code FPA
Combination Product (y/n)N
Reporter Country CodeFR
PMA/PMN Number
K082806
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,Company Representative
Reporter Occupation Pharmacist
Type of Report Initial,Followup
Report Date 02/06/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue NumberCH2000S-PC
Device Lot Number5891845
Was Device Available for Evaluation? Yes
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 11/23/2023
Initial Date FDA Received12/07/2023
Supplement Dates Manufacturer Received01/24/2024
Supplement Dates FDA Received02/06/2024
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured03/01/2022
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
BUSULFAN-MELPHALAN, MFR UNK; UNSPEC. PULMONARY ARTERY CATHETER (PAC), MFR UNK; UNSPECIFIED SYRINGE, MFR UNK
Patient Age5 YR
-
-